The $150 million was an advance payment. It was intended to support at-risk manufacturing by Medicago, meaning that Medicago had to proceed to conduct activities before it knew whether it would have Health Canada authorization. That represented a risk for the company. These payments were intended to fund those at-risk activities.
On December 4th, 2023. See this statement in context.